Eamon Comer

Eamon Comer has extensive work experience in the field of medicinal chemistry. Eamon is currently employed at Kymera Therapeutics, where they hold the position of Director of Medicinal Chemistry starting in February 2023. Prior to this role, they served as the Associate Director of Medicinal Chemistry at Kymera Therapeutics from February 2022 to January 2023.

Before joining Kymera Therapeutics, Eamon worked at Faze Medicines as the Director of Medicinal Chemistry from September 2021 to February 2022. Eamon also had a significant role at Epizyme, where they held the position of Associate Director of Medicinal Chemistry from December 2018 to August 2021.

Eamon's career in medicinal chemistry began at the Broad Institute of MIT and Harvard, where they were a Group Leader from April 2007 to December 2018. Previously, they worked as a Postdoctoral Scientist at Boston University from April 2005 to April 2007, and as a Postdoctoral Fellow at York University from April 2003 to April 2005.

Overall, Eamon Comer has accumulated a wealth of experience and expertise in medicinal chemistry, holding various leadership positions in reputable organizations.

Eamon Comer completed their BSc in Pure and Applied Chemistry from Dublin City University from 1993 to 1997. Subsequently, they pursued a PhD in Organic Chemistry from University College Cork from 1997 to 2002.